Yeboah Eugene K, Seshan Surya V, Pariya Fnu, Khan Sulayman, Azhar Muhammad, Salifu Moro, Saggi Subodh
Internal Medicine, State University of New York Downstate Medical Center, Brooklyn, USA.
Pathology and Laboratory Medicine, Weil Cornell Medicine, New York, USA.
Cureus. 2025 Mar 23;17(3):e81031. doi: 10.7759/cureus.81031. eCollection 2025 Mar.
A 41-year-old male with a history of chronic kidney disease, hypertension, and psoriasis was referred to the nephrologist for worsening kidney function associated with nephrotic range proteinuria. The patient had no symptoms, but the initial workup showed elevated erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), positive double-stranded DNA antibody(anti-DsDNA) but normal complement levels, normal antinuclear antibody (ANA) and negative beta-glycoprotein-1 IgG, IgM, and IgA. Further, the workup revealed the patient had elevated total immunoglobulin as well as elevated IgG subsets 2, 3, and 4. He was also found to have a high variant of apolipoprotein L1 (APOL1). A renal biopsy revealed diffuse active, subacute, and chronic interstitial inflammation, plasma cell-rich (25% IgG4 positive), confirming IgG4-related tubulointerstitial nephritis with concomitant IgG4 dominant, PLA2R negative membranous glomerulonephritis. There was also a severe podocytopathy in the form of diffuse segmental/global collapsing glomerulopathy with sclerosing changes as well as global glomerulosclerosis, extensive tubular atrophy with mild interstitial changes suggestive of a variant of focal segmental glomerulosclerosis (FSGS). A diagnosis of APOL-1 collapsing glomerulopathy with IgG4 nephropathy was made based on clinical and pathological findings. The patient's kidney function stabilized, and IgG4 levels returned to normal after the patient was initiated on 60 mg daily prednisolone. The steroid was tapered off and the patient was started on mycophenolate mofetil 1000 mg twice daily. To our knowledge, this is the first reported case of IgG4-related kidney disease with concurrent severe APOL1-associated collapsing glomerulopathy.
一名41岁男性,有慢性肾病、高血压和银屑病病史,因肾病范围蛋白尿导致肾功能恶化而被转诊至肾病科医生处。患者无症状,但初步检查显示红细胞沉降率(ESR)、C反应蛋白(CRP)升高,双链DNA抗体(抗DsDNA)阳性但补体水平正常,抗核抗体(ANA)正常,β-糖蛋白-1 IgG、IgM和IgA阴性。此外,检查发现患者总免疫球蛋白升高,IgG亚群2、3和4也升高。还发现他有载脂蛋白L1(APOL1)的高变异体。肾活检显示弥漫性活动性、亚急性和慢性间质性炎症,富含浆细胞(25% IgG4阳性),证实为IgG4相关性肾小管间质性肾炎,同时伴有IgG4占主导、PLA2R阴性的膜性肾小球肾炎。还存在严重的足细胞病,表现为弥漫性节段性/全球性塌陷性肾小球病伴硬化改变以及全球性肾小球硬化,广泛的肾小管萎缩伴轻度间质改变,提示局灶节段性肾小球硬化(FSGS)的一种变异型。根据临床和病理结果,诊断为APOL-1塌陷性肾小球病合并IgG4肾病。患者开始每日服用60mg泼尼松龙后,肾功能稳定,IgG4水平恢复正常。逐渐减少类固醇剂量,患者开始每日两次服用1000mg霉酚酸酯。据我们所知,这是首例报告的IgG4相关性肾病并发严重APOL1相关性塌陷性肾小球病的病例。